Skip to main content
Clinical Trials/JPRN-UMIN000026084
JPRN-UMIN000026084
Completed
未知

Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT) - Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)

agoya University Graduate School of Medicine0 sites10 target enrollmentMay 1, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)
Sponsor
agoya University Graduate School of Medicine
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2017
End Date
June 12, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
agoya University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1 active double cancer 2 active infection needed systemic therapy 3 body temperature more than or equal to 38 degrees C 4 in pregnancy, breastfeeding, strong possibility of pregnancy 5 positive in HBs antigen, HBV\-DNA, HCV antibody 6 positive in HIV antibody(no measurement is OK) 7 inadequate for other reason by doctor's assessment

Outcomes

Primary Outcomes

Not specified

Similar Trials